Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicity
{{output}}
Personalized escalation and de-escalation of immune checkpoint inhibitor (ICI) regimens may help to overcome upfront resistance and mitigate the risk for immune-related adverse events (irAEs). Here, we examined the association between pathological response and... ...
